SmithKline Beecham plc v Alphapharm Pty Ltd [2001] FCA 1324

SmithKline Beecham plc v Alphapharm Pty Ltd [2001] FCA 1324

The applicants had not shown exceptional circumstances warranting reopening the earlier refusal to order provision of tablet samples. The raw material samples could be tested without limiting the applicants to particular techniques, because no such restriction had been sought at the hearing, no injustice was shown, and the applicants were entitled to check the validity of supplied test results. Access by a nominated director and patent attorneys could be allowed under undertakings, but undertakings excluding involvement in infringement proceedings outside Australia were required to quarantine confidential information because the risk of subconscious breach in relation to United States...

Jurisdiction
Australia
Judgment Date
18 April 2001
Procedural Posture
Application for Preliminary Discovery in Contemplated Patent Infringement Proceedings / Determination of Outstanding Disputes as to the Form of Orders After Reasons for Orders Under O 15 a R 12 of the Federal Court Rules
Outcome
Orders made requiring provision of raw material samples and confidentiality protections; applicants' request for tablet samples refused; respondents' requests to limit testing, obtain indemnity costs, and avoid sample production refused.
Legal Topics
['preliminary Discovery' 'provision of Samples' 'confidentiality Orders' 'undertakings' 'reopening or Rehearing' 'costs']

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 1 Authorities cited 2 Party arguments 2 Amounts and remedies 1
Sign in to unlock

Procedural Posture

Application for Preliminary Discovery in Contemplated Patent Infringement Proceedings / Determination of Outstanding Disputes as to the Form of Orders After Reasons for Orders Under O 15 a R 12 of the Federal Court Rules

  1. 1 ['Whether the applicants should receive tablet samples as well as samples of raw material' 'Whether tests on the raw material samples should be limited to NMR, DSC and melting point analyses' "Whether access to the raw material samples should be restricted so that the applicants' patent attorneys and a nominated director could not inspect them" 'Whether the respondents should receive indemnity costs if no infringement proceeding was commenced by 1 August 2001' 'Whether recent United States infringement proceedings meant that no samples should be provided and no orders should be made under O 15A' 'Whether undertakings should quarantine confidential information from use in infringement proceedings outside Australia']

Ratio Decidendi

The applicants had not shown exceptional circumstances warranting reopening the earlier refusal to order provision of tablet samples. The raw material samples could be tested without limiting the applicants to particular techniques, because no such restriction had been sought at the hearing, no injustice was shown, and the applicants were entitled to check the validity of supplied test results. Access by a nominated director and patent attorneys could be allowed under undertakings, but undertakings excluding involvement in infringement proceedings outside Australia were required to quarantine confidential information because the risk of subconscious breach in relation to United States...

Court Disposition

Orders made requiring provision of raw material samples and confidentiality protections; applicants' request for tablet samples refused; respondents' requests to limit testing, obtain indemnity costs, and avoid sample production refused.

Orders

  • ['The applicants were relieved of their undertaking dated 18 December 2000.' "The confidential annexure to the first respondent's undertaking dated 18 December 2000 was made an open record in the court file." "By 4.00pm on 27 April 2001, the first respondent was ordered to provide the applicants' solicitors a 50...